Age-Adjusted D-dimer Threshold for VTE
In patients ≥50 years with low-to-moderate pre-test probability of PE or DVT, D-dimer threshold is increased using the formula: age × 10 µg/L (or × 10 ng/mL). This increases specificity while maintaining sensitivity, reducing unnecessary imaging. Validated by ADJUST-PE and multiple meta-analyses.
Score interpretation
D-dimer below standard 500 µg/L threshold
→ If pre-test probability low/unlikely: VTE excluded — no imaging needed; cease anticoagulation if already started; document clinical decision; advise patient on VTE symptoms for re-presentation
D-dimer ≥500 µg/L — above standard threshold; check if below age-adjusted threshold (age × 10) for patients ≥50
→ Calculate age-adjusted threshold (age × 10 µg/L): if D-dimer < age × 10 AND age ≥50 AND low/moderate pre-test probability → VTE excluded without imaging; if D-dimer ≥ age × 10 → proceed to CT pulmonary angiography (CTPA) for PE or lower limb ultrasound for DVT; anticoagulate if imaging positive
D-dimer markedly elevated — proceed to imaging regardless of age
→ Proceed to CTPA for PE or compression ultrasound for DVT; consider empirical anticoagulation while awaiting imaging if pre-test probability high; if imaging confirms PE/DVT: initiate therapeutic anticoagulation per NICE NG158 (DOAC preferred); consider haematology input for unprovoked or recurrent VTE; investigate for underlying malignancy if first unprovoked VTE
Interpretation bands for the Age-Adjusted D-dimer. Apply clinical judgement and local guidance.
References
- Righini M et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117–1124.
- NICE NG158. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. 2020 (updated 2023).
Related
Curated clinical cross-links plus same-class fallbacks.
- Nitric Oxide (Inhaled — iNO) · Selective Pulmonary Vasodilator
- Selexipag · Pulmonary Arterial Hypertension
- Macitentan · Pulmonary Arterial Hypertension
- Lissamine Green 1% Eye Drops · Vital Dye — Ocular Surface Staining (Dry Eye Diagnosis)
- Sildenafil (Paediatric — PPHN / PAH) · PDE5 Inhibitor (Paediatric Pulmonary Hypertension)
- Sildenafil · PDE5 Inhibitor — Pulmonary Arterial Hypertension
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.